Agios Pharmaceuticals Inc.

07/07/2026 | Press release | Distributed by Public on 07/07/2026 05:07

U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease

Agios Pharmaceuticals Inc. published this content on July 07, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 07, 2026 at 11:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]